FDA Approved: ROSUVASTATIN — Supplemental Application (Accord Healthcare Inc.)

View source ↗

Summary

FDA approved a supplemental application for rosuvastatin from Accord Healthcare Inc. (ANDA 206434).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Familial Hypercholesterolemia
• Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

SUPPL AP for ROSUVASTATIN (ROSUVASTATIN)